FDA regulatory momentum includes priority review and breakthrough therapy designation for a potential first-in-class CHB ...
The decision by the Center for Disease Control and Prevention to stop recommending giving infants a dose of the hepatitis B ...
Lytical’s iStatis test delivers results in 15 minutes in clinical and community settings iStatis Hepatitis B Surface Antigen ...
Delayed hepatitis B vaccination in infants whose birth parents tested negative for HBsAg is associated with adverse health outcomes.
Countries are making measurable progress in combatting viral hepatitis, but the disease remains a major global health ...
US model study suggests a targeted hepatitis B birth-dose strategy could increase neonatal infections unless screening and ...
CLEVELAND - A family physician pressed Health and Human Services Secretary Robert F. Kennedy Jr. Thursday on one of the most ...
The World Health Organization (WHO) released a new report on hepatitis today, marking the World Hepatitis Summit. Since 2015, ...
HBV infection at birth or during early infancy can lead to lifelong health problems such as chronic liver disease and liver ...
Phase 3 trial results demonstrate that bepirovirsen significantly increases the proportion of patients achieving functional cure compared with placebo.
Researchers found that the decision to delay the once-universal hepatitis B shot for babies will likely cause a surge in ...
If someone presents you with a hepatitis B declination form, you might have some questions about it and the hepatitis B vaccine more generally. Hepatitis B is an infection of the liver due to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results